Catalyst Wire Dossier Catalyst Wire Dossier

KRX-101

· Keryx Biopharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KRX-101, covering 2017-03-03 to 2017-03-03. Get the full timeline:

Most recent: Clinical Trial Update: Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong Kong [Phase 3]

See pricing